Prepared by: Purva Chandak

1. Morocco:
Capital:
Rabat

Morocco is increasingly becoming an important

industrial player in the EMEA region due to its
location as it serves as a stepping stone to Africa and
the Middle East. Having experienced an average
growth of 4.4% in its GDP over the last 15 years, there
are strong indications that its economic growth will
continue to improve.

Population:
34.3 Million

Currency:
Moroccan Dirham

Exchange Value in USD:       

1000 Moroccan Dirham equivalent to 108.26 USD

GDP (Purchasing Power Parity)

$298.6 billion (2017 est.)

GDP per capita (Purchasing Power Parity)

$8,600 (2017 est.)

Official Language:
Arabic official language, preferred foreign language is French.

Destination Sea Port or Airport:   

Mohammed V International Airport (IATA: CMN) is the largest airport in Morocco.

International Borders/Surrounding Countries:

Morocco is a country in northern Africa.
North - Mediterranean Sea
West – Atlantic ocean
East – Algeria
South – Western Sahara
Morocco shares maritime borders with 14 countries.

Pharma Market Value:

Morocco market had just above ~1.1 Bn sales in 2018.
Sanofi with $93Mn sales is the leading player, local company Bottu S.A’s Doliprane
(paracetamol) with $56Mn sales is the top selling brand and Polymedic (b. $16 M) with 17%
PPG is the fastest growing corporation.

Market Share:

Healthcare Budget:

Healthcare spending
165
160
155
150
145
140
2015 2016 2017

Healthcare spending

Market Growth:
Average growth of 5% last year.

FDA:
Regulatory procedures are under the control of the Drugs and Pharmaceutical
Directorate of the Ministry of Health. The latter is divided into three subdirections:
 Division of Pharmacy (responsible inter alia of clinical drug evaluation,
registration and pricing where appropriate);
 Pharmaceutical sector monitoring department (e.g. scheduling inspections in
order to establish GMP certificate)
 LNCM which is responsible of the quality review of pharmaceutical
documentations as well as of lab-testings.

Registration Time:
The average time to obtain a certificate of registration is six months.

Validity of Registration:

Registration Fees:

Type of Dossier: 
In Morocco, the dossier can be submitted in CTD format.

Name of Tender Body:

Indian Pharma Companies:

Sun Pharma is one of the fastest growing pharmaceutical companies in Morocco and
currently market 19 brands across the anti-infective, neuro-psychiatry, cardiovascular,
urology and critical care therapeutic areas. They started their manufacturing
operations in Casablanca in March 2012.

Significant points:
 Morocco is among the North African countries benefiting from a higher
political stability, a liberal economy and an educated workforce; practically,
all important elements in order to attract foreign investments.
 This is paralleled, in the pharmaceutical and healthcare areas, by the
liberalisation of the capital stock of pharmaceutical companies and, from the
regulatory perspective, from a reform that took place in 2006 aimed to
improve the compliance to ICH recommendations and international quality
standards for manufacturing of medicinal products.
 Prices of medicines have also been repeatedly reduced in the period 2010-
2016, a possible element lowering the appeal of the country for foreign
investors. A new price decree was adopted by government in December 2013
comparing ex-factory prices of countries of reference (France, Spain, Portugal,
Saudi Arabia, Turkey, Belgium, and the country of origin when it is different
from the mentioned list).
 70% population goes to public hospital.
Characteristics of the market:
 Steadily growing population.
 Strategic location in northern Africa facilitates access to markets around the
EMEA region, with direct manufacturing operations that serve sub-Saharan
Africa there. Morocco is an ideal region to serve Egypt, Algeria and other
emerging markets in the region.
 Price competitiveness, high skilled workforce
 Developed infrastructure.
Disease Burden:

Selected Adult Risk Factor Trends:

Top therapy areas:

Causes of Death and Disability compared with other locations:

Disease trend and Risk factors:
Important links:

1. https://2016.export.gov/industry/health/healthcareresourceguide/eg_main_108604.asp
2. https://www.ijsr.net/archive/v5i11/ART20162892.pdf